SCOTTSDALE, Ariz.--(BUSINESS WIRE)--ImmuneRegen BioSciences, Inc., a wholly-owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBO) today announced the appointment of Pranela Rameshwar, Ph.D., to its scientific advisory board. Dr. Rameshwar has been directing academic research programs for over 15 years and is an internationally-recognized thought leader in the field of regenerative medicine, genetics, and stem cell research.
